ADAM8 and neoplasm: JG26 and compounds 1–3 were finallytested (Figure 5) fortheir capacity to affect the invasive potential of tumor cells, aneffect that, at least in part, is dependent on the ADAM8 proteolyticactivity, as ADAM8-deficient cell lines suggest.5,7